ANKARA — Physicians have launched the world’s first mRNA lung cancer vaccine trial across seven countries, including Türkiye, in a groundbreaking effort that could revolutionize cancer treatment, according to press reports on Friday.
The vaccine, known as BNT116 and developed by BioNTech, is designed to target non-small cell lung cancer (NSCLC), the most common type of lung cancer.
THREE corporations belonging to the Sy family conglomerate lead the 13 Philippine firms that made Time Magazine and Statista’s list of World’s Best Companies for 2024. SM Investments Corp. (SMIC) ranked 502nd in the list, […]
THE Philippines will be the president-nominee in the 78th World Health Assembly (WHA) to be held in Geneva, Switzerland, in May 2025, the first time the country will lead the assembly since the World Health […]
TOKYO — The world’s first wooden satellite has blasted off on a SpaceX rocket, its Japanese developers said Tuesday, part of a resupply mission to the International Space Station. Scientists at Kyoto University expect the […]
Copyright ©2024 New Babylon Group of Companies OPC
Be the first to comment